Results 181 to 190 of about 12,236 (230)
Pharmacovigilance study of drug-induced eye movement disorder based on FDA adverse event reports from 2004 to 2024. [PDF]
Hong SY +5 more
europepmc +1 more source
Investigation into visual defects attributed to Vigabatrin
Miriam L. Conway
openalex +1 more source
Mechanistic strategies for secondary prevention of developmental and epileptic encephalopathy in children with tuberous sclerosis complex. [PDF]
Specchio N +4 more
europepmc +1 more source
Visual Function Characteristics in <i>STXBP1</i> Epileptic Encephalopathy Patients. [PDF]
Rosa A +11 more
europepmc +1 more source
Diagnosis and Management of Keppen-Lubinsky Syndrome in a Lebanese Infant: A Case Report. [PDF]
Fakih H.
europepmc +1 more source
Severe persistent visual field constriction associated with vigabatrin
Elaine A. Wilson, M J Brodie
openalex +2 more sources
"Time to Feed the Baby": Should There Be a Paradigm Change in the Treatment of Infantile Epileptic Spasms Syndrome? [PDF]
Phitsanuwong C.
europepmc +1 more source

